Traws Pharma Inc (TRAW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,726 | 16,970 | 4,024 | 21,450 | 19,849 |
| Receivables | 98 | 35 | 59 | 31 | 1,504 |
| TOTAL | $23,474 | $17,765 | $4,903 | $23,069 | $23,185 |
| Non-Current Assets | |||||
| PPE Net | 50 | 9 | 64 | 152 | 248 |
| Other Non-Current Assets | 150 | 149 | 12 | 12 | 12 |
| TOTAL | $200 | $158 | $76 | $164 | $260 |
| Total Assets | $23,674 | $17,923 | $4,979 | $23,233 | $23,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,271 | 4,039 | 6,186 | 5,323 | 3,421 |
| Accrued Expenses | 3,795 | 4,173 | 3,335 | 4,382 | 3,729 |
| TOTAL | $8,292 | $8,438 | $9,976 | $10,160 | $7,605 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 226 | 226 | 455 | 455 | 455 |
| Other Non-Current Liabilities | 113 | 13 | 1,773 | 3,401 | 44 |
| TOTAL | $3,808 | $4,098 | $5,864 | $7,946 | $5,000 |
| Total Liabilities | $12,100 | $12,536 | $15,840 | $18,106 | $12,605 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 446 | 16 | 3 | 1 | 0 |
| Common Shares | 1,112 | 57 | 8 | 68 | 25 |
| Retained earnings | -403,399 | -381,896 | -362,316 | -338,224 | -318,557 |
| Other shareholders' equity | -18 | -12 | 833 | 799 | 808 |
| TOTAL | $11,574 | $5,387 | $-10,861 | $5,127 | $10,840 |
| Total Liabilities And Equity | $23,674 | $17,923 | $4,979 | $23,233 | $23,445 |